Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Promis Neurosciences (PMN) had Weighted-Average Shares Outstanding (Diluted) of 1.76M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-10.67M |
|
-- |
|
-- |
|
$10.77M |
|
$-10.77M |
|
$0.10M |
|
$-10.67M |
|
$-10.67M |
|
$-10.67M |
|
$-10.67M |
|
$-10.67M |
|
$-10.67M |
|
$-10.77M |
|
$-10.77M |
|
1.76M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
1.76M |
$-4.11 |
|
$-4.11 |
|
| Balance Sheet Financials | |
$9.18M |
|
-- |
|
-- |
|
$9.18M |
|
$10.41M |
|
-- |
|
$0.03M |
|
$10.44M |
|
$-1.26M |
|
$-1.26M |
|
$-1.26M |
|
2.15M |
|
| Cash Flow Statement Financials | |
$-28.12M |
|
$-0.00M |
|
$20.94M |
|
$13.29M |
|
$6.12M |
|
$-7.17M |
|
$0.86M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.88 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-28.12M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
848.10% |
|
848.10% |
|
-116.24% |
|
848.10% |
|
$-0.58 |
|
$-16.00 |
|
$-16.00 |
|